Increasing evidence indicates that STAT6 also contributes to tumor formation, and STAT6 activation is often observed in many malignancies, including follicular lymphoma, colon cancer, and classical Hodgkin lymphoma[13–16]. Here, STAT6 is linked to neoplasm.